ET Now on MSN: Weight-loss drug price war erupts! Amid sales decline, can Mounjaro hold ground as cheaper rivals flood market? Weight-loss drug price war erupts!

Context Explanation

Amid sales decline, can Mounjaro hold ground as cheaper rivals flood market? The Globe and Mail: Public health plans should cover Mounjaro for Type 2 diabetes, Canada’s Drug Agency recommends Public health plans should cover the blockbuster drug Mounjaro for patients with type 2 diabetes, Canada’s Drug Agency says, as long as manufacturer Eli Lilly Split N/A N/A 08/29/22 N/A 08/29/22 N/A 1 ... Public health plans should cover Mounjaro for Type 2 diabetes, Canada’s Drug Agency recommends The Financial Express: Mounjaro takes a hit as generic weight-loss medicines flood the market Yahoo Finance: How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q1 Results? Eli Lilly's Q1 revenues are expected to reflect strong Mounjaro and Zepbound demand, as supply gains and global uptake offset pricing pressure.

Insight Material